Treprostinil

Products

Treprostinil is commercially available as an infusion solution (Remodulin, generic). It has been approved in many countries since 2004.

Structure and properties

Treprostinil (C23H34O5, Mr = 390.5 g/mol) is a synthetic prostacyclin.

Effects

Treprostinil (ATC B01AC21) has vasodilator and antiplatelet properties.

Indications

  • Primary pulmonary hypertension
  • Pulmonary arterial hypertension